☰

Brent J. Yamamoto, Ph.D. - Publications

Affiliations: 
2006 Washington State University, Pullman, WA, United States 
Tree Info Grants Similar researchers PubMed Report error

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Kawas LH, Church KJ, Lange M, Mcmicheal M, Yamamoto B, Harding JW. Abstract 729: Norleual a hepatocyte growth factor/c-Met inhibitor blocks malignant phenotypes in cancerous cells Cancer Research. 74: 729-729. DOI: 10.1158/1538-7445.Am2014-729  0.74
2012 Kawas LH, McCoy AT, Yamamoto BJ, Wright JW, Harding JW. Development of angiotensin IV analogs as hepatocyte growth factor/Met modifiers. The Journal of Pharmacology and Experimental Therapeutics. 340: 539-48. PMID 22129598 DOI: 10.1124/Jpet.111.188136  0.707
2011 Kawas LH, Yamamoto BJ, Wright JW, Harding JW. Mimics of the dimerization domain of hepatocyte growth factor exhibit anti-Met and anticancer activity. The Journal of Pharmacology and Experimental Therapeutics. 339: 509-18. PMID 21859930 DOI: 10.1124/Jpet.111.185694  0.75
2011 Kawas LH, Harding JW, Yamamoto BJ, Wright JW. Abstract 1356: The Hinge (linker) region of the Hepatocyte Growth Factor (HGF) peptide sequence can act as Hepatocyte Growth Factor/c-Met inhibitor Cancer Research. 71: 1356-1356. DOI: 10.1158/1538-7445.Am2011-1356  0.754
2010 Yamamoto BJ, Elias PD, Masino JA, Hudson BD, McCoy AT, Anderson ZJ, Varnum MD, Sardinia MF, Wright JW, Harding JW. The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2)3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor/c-Met inhibitor. The Journal of Pharmacology and Experimental Therapeutics. 333: 161-73. PMID 20086056 DOI: 10.1124/Jpet.109.161711  0.581
2008 Wright JW, Yamamoto BJ, Harding JW. Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets. Progress in Neurobiology. 84: 157-81. PMID 18160199 DOI: 10.1016/J.Pneurobio.2007.10.009  0.527
Show low-probability matches.